Tenet Healthcare (THC) Tops Q3 EPS by $1.03, Guidance Beats

Go back to Tenet Healthcare (THC) Tops Q3 EPS by $1.03, Guidance Beats

Tenet Reports Third Quarter 2021 Results; Raises 2021 Financial Guidance

October 20, 2021 4:10 PM EDT

Net income from continuing operations available to common shareholders in Q321 of $448 million versus a net loss from continuing operations of $197 million in Q320 Consolidated Adjusted EBITDA in Q321 of $855 million ($851 million excluding $4 million of COVID stimulus grant income) versus $551 million in Q320 ($621 million excluding $(70) million of grant income) Diluted earnings per share from continuing operations available to common shareholders in Q321 of $4.12 compared to a loss per share of $1.87 in Q320; Adjusted diluted earnings per share from continuing operations of $1.99 in Q321 compared to $0.64 in... More